What are the top competitors of BLC.PA in Healthcare sector?

The top competitors of BLC.PA in the Healthcare sector are: Uniphar plc (UPR.IR), Metrics in Balance N.V. (MLMIB.PA).

Which has better valuations & earnings, BLC.PA or its competitors?

BLC.PA has a market cap of 195.8M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: BLC.PA or its competitors?

BLC.PA has an EPS of €1.16, while UPR.IR has an EPS of €0.23. So, BLC.PA is more profitable compared to UPR.IR.

What is BLC.PA stock volatility and risk in terms of investment?

BLC.PA has daily volatility of 4.42% as compared to its competitor UPR.IR which is 2.91%. BLC.PA is more volatile as compared to competitors and has high risk.

Is BLC.PA stock profitable?

BLC.PA has a Return on Equity (ROE) of 0.02%. So, BLC.PA is more profitable.

What is BLC.PA stock’s 52 weeks high and low?

BLC.PA stock has a 52-week high of (€29.6) and a low of (€17.3).

What was the average volume of BLC.PA stock?

The average volume of BLC.PA is (6.7K) in terms of investment.

Bastide Le Confort Médical SA (BLC.PA) Competitors

Bastide Le Confort Médical SA BLC.PA Peers

See (BLC.PA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Distribution Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
BLC.PA	€26.80	-0.92%	195.8M	23.10	€1.16	N/A
UPR.IR	€3.61	-0.69%	937.1M	15.70	€0.23	+0.53%
MLMIB.PA	€0.03	N/A	790.3K	-3.30	-€0.01	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BLC.PA vs UPR.IR Comparison

BLC.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BLC.PA stands at 195.8M. In comparison, UPR.IR has a market cap of 937.1M. Regarding current trading prices, BLC.PA is priced at €26.80, while UPR.IR trades at €3.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BLC.PA currently has a P/E ratio of 23.10, whereas UPR.IR's P/E ratio is 15.70. In terms of profitability, BLC.PA's ROE is +0.02%, compared to UPR.IR's ROE of +0.08%. Regarding short-term risk, BLC.PA is more volatile compared to UPR.IR. This indicates potentially higher risk in terms of short-term price fluctuations for BLC.PA.

Bastide Le Confort Médical SA